Biotechnol. Redox activated polymeric nanoparticles in tumor therapy (Elsevier, Amsterdam, 2017). Similarly, complete tumor eradication has been achieved employing cut-single walled carbon nanotubes coated with BSA-reduced Au nanoparticles, enhancing doxorubicin drug release when combined with phototherapy with an 808nm laser in a nude mouse model [202]. Pharm. 12(11), 958 (2013), H. Lee et al., In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels. Applications, advantages and disadvantages of Nanotechnology 2018;9(1):3490. doi: 10.1038/s41467-018-05467-z. The development of nanotechnology is based on the usage of small molecular structures and particles as tools for delivering drugs. The surface chemistry of the nanomaterials can provide control of the therapeutic effects by reducing the potential undesired side effects. Natl. In redox-activated drug release mechanism, a redox-responsive nanocarrier containing functional groups that reacts upon contact with oxidizing and/or reducing environment in and around cancer cells (peroxides, GSH, and free radicals), undergoing to chemical bond cleavage [63]. Chem. The heat generated due to Neel and Brownian relaxation as well as hysteresis loss can be used to kill tumor cells in the vicinity of IONPs [49]. have developed different shaped mesoporous silica nanoparticles (sphere, rod, and long rod) functionalized with fluorescein isothiocyanate (FITC) and rhodamine B isothiocyanate (RITC) for imaging and quantification of mesoporous silica nanoparticle uptake. 60(11), 13071315 (2008), O.R. Natl. Nanoparticles (NP) have been used in tumor therapies as appropriate tools for enhancing drug delivery efficacy and enabling . 128(46), 1479214793 (2006), Z. Liu et al., Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. Furthermore, Au nanoparticles coated with Pc4, a fluorescent photodynamic therapy (PDT) drug have been developed by functionalizing prostate-specific membrane antigen (PSMA-1) ligand to actively target the disease biomarkers to increase tumor residence time, and internalization by receptor-mediated endocytosis. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. G4.0-polyamide amine-HEP-mPEG revealed precise release of doxorubicin and had prolonged retention compared to pristine doxorubicin in both Hela and fibroblast NIH3T3 cancer cells. 7(7), 1701143 (2017), Y. Wen, J.K. Oh, Intracellular delivery cellulose-based bionanogels with dual temperature/pH-response for cancer therapy. A clear understanding of these factors will provide important synthesis strategies for targeted nanoparticles therapyactive or passive targeting alike. Another key issue is the challenge of regulatory approval of nanomedicines, as there are no specific guidelines set by FDA for the products with nanomaterials. 217(3), 205216 (2013), Z. Ji et al., Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. Pharmacother. Correspondence to Med. Moreover, the studies of Villanueva et al. Biomaterials 133, 208218 (2017), H. Zhang et al., Visible-light-sensitive titanium dioxide nanoplatform for tumor-responsive Fe2+ liberating and artemisinin delivery. As cancer is known to be a consequence of DNA defects, many countries are battling with nipping it in the bud, particularly developing nations [41]. Sci. Thus, it is imperative to develop effective formulations that can address the above cited challenges and provide selective targeting of tumor sites without significant damage to the viability of healthy tissues [3,4,5,6,7,8,9]. Nanoparticles are classified into several main categories. Pharm Res. by A. Dhawan (CRC Press, Boca Raton, 2018), pp. Illustration of TMZ (temozolomide) and siRNA conjugated preparation of folic acid decorated Fa-PEG-PEI-PCL and release of antitumor therapeutics inside the cancer cells (a); TEM images showing TMZ-conjugated, folic acid-decorated PEC micelle (left) and TMZ and siRNA-conjugated, folic acid-decorated PEC micelle (right) at pH 7.4. Due to the lack of understanding of toxicity and in vivo behaviour of nanoformulations, clinical trials are experiencing major setbacks. Release 172(3), 852861 (2013), S.K. Control. Expert Opin. Acta Biomater. 9(3), 10801084 (2009), C. He et al., Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. AK acknowledges International Max Planck Research School (IMPRS) Fellowship (Molecular Biology) from the Max Planck Society, Germany (2016-18) and Melbourne Research Scholarship for the support of his research at the University of Melbourne. Sci. B Biointerfaces 169, 265272 (2018), A. Mohammadi Gazestani et al., In vivo evaluation of the combination effect of near-infrared laser and 5-fluorouracil-loaded PLGA-coated magnetite nanographene oxide. Int. The efficient delivery of nanomaterials to the target tissues can be classified as passive and active targeting, as discussed below. In addition to all the above, a significant setback in nanomedicine commercialization is the clinical translation due to the lack of in-depth understanding of nano-bio interfacial interactions. Eng. ACS Appl. Biomaterials 31(30), 76067619 (2010), S.D. 34, 7000 (2016), V.P. Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing - PubMed Hence nanotechnology has a deep impact on the environment. In my study I found different disadvantages of using nanoparticles in water and wastewater treatment such solubility, increasing TOC and difficulty of collecting after treatment I need your. 46, 11381148 (2018), H. Banu et al., Gold and silver nanoparticles biomimetically synthesized using date palm pollen extract-induce apoptosis and regulate p53 and Bcl-2 expression in human breast adenocarcinoma cells. Xia et al., constructed a pH sensitive liposome formulation by loading tariquidar (TQR) and doxorubicin to overcome multidrug resistance of drug-resistant ovarian cancer cells. The nanoparticle drug delivery system is particular and utilizes tumor and tumor environment characteristics. Advances and Implications in Nanotechnology for Lung Cancer - PubMed For instance, Ag nanoparticles synthesized using Indigofera hirsuta leaf extract and pollen extract of Phoenix dactylifera showed dose-dependent cytotoxicity against different cancers [149, 150]. Daima et al., Complexation of plasmid DNA and poly(ethylene oxide)/poly(propylene oxide) polymers for safe gene delivery. Ag nanoparticles conjugated with phytopharmaceuticals can serve as non-toxic delivery vehicles, contrast agents and photothermal agents for cancer therapy. There are those who suggest concerns about nanotechnology may be over-exaggerated. Theranostics 8(3), 693709 (2018), G. Wang et al., Theranostic hyaluronic acid-iron micellar nanoparticles for magnetic-field-enhanced in vivo cancer chemotherapy. Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini At this stage, it can be envisioned that improvement in materials is possible for nextgeneration nanomedicine through smart design, andnew developments can provide better cancer managment strategies. Federal government websites often end in .gov or .mil. Pept. Liposomes are spherical vesicles composed of a lipid bilayer of either synthetic or natural phospholipids surrounding an internal aqueous phase. Current nanotechnology-based treatments such as Abraxane and Doxil do cause side effects like weight loss, nausea, and diarrhea. 10, 975999 (2015), T. Zhang et al., Polysialic acidpolyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. The in vitro cytotoxicity studies revealed that doxorubicin formulations had increased antiproliferative effect and was time and dose-dependent as depicted in Fig. 96, 1121 (2015), X. Xie et al., EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. J. Pharm. Eng. J. Toxicol. 520(1), 126138 (2017), C.T. PEG-PLGA nanoparticles were conjugated with AS1411, a DNA aptamer, that binds to a protein highly expressed in the plasma membrane of cancer and the endothelial cells of angiogenic blood vessels. Nano Lett. A novel drug delivery system based on carbon nanospheres for delivery of cancer therapeutics has been evaluated for internalization, and possible mechanism of endocytosis and biodistribution in mice [206]. However, in some tumor cases the size of nanoparticles should be tuned according to the vasculature lining gap size [59]. 46, 921935 (2018), W. Xu et al., Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells. Polym. J. Pharm. 15(6), 21942205 (2018), M.U. In addition to tailoring the surface corona, engineered nanomaterials reduce their toxicity and enhance their stability [23, 44, 119]. J. Pharm. 3. This heterogeneity adds another layer of complexity to passive targeting. Int. Generally, only small quantities of nanomedicine are used for pre-clinical and clinical trial studies. B Appl. 2023 Feb 26;15(3):774. doi: 10.3390/pharmaceutics15030774. 65, 393404 (2018), H.K. Brito C, Loureno C, Magalhes J, Reis S, Borges M. Vaccines (Basel). Ligand density on the nanoparticles dictates the strength of avidity towards the substrate, so approaches used to conjugate ligands on the surface of nanoparticles are critical aspects of the targeted systems. 15(5), 17911799 (2018), D. Cui et al., Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer. Nanotechnology advances in drug delivery deal with the development of synthetic nanometer sized targeted delivery systems for therapeutic agents Currently used drug delivery systems, such as . Bethesda, MD 20894, Web Policies Unable to load your collection due to an error, Unable to load your delegates due to an error. C 79, 465472 (2017), V. Gnanavel, V. Palanichamy, S.M. Mater. 29(5), 65 (2018), W. Cheng et al., A drug-self-gated and tumor microenvironment-responsive mesoporous silica vehicle: four-in-one versatile nanomedicine for targeted multidrug-resistant cancer therapy. Nevertheless, it is essential to choose the right type of ligand for improvedand efficient targeting of the tumor cells. Nanomedicine 10(8), 12331246 (2015), Y. Zhang et al., Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery. Int. C 53, 298309 (2015), M. Ramar et al., Synthesis of silver nanoparticles using Solanum trilobatum fruits extract and its antibacterial, cytotoxic activity against human breast cancer cell line MCF 7. 22(27), 1377313781 (2012), Y. Wang et al., Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Studies show that the pH value drops to around 6.5 from physiological pH of 7.4 during the tumoral metastasis or development [66]. 12(8), 28112822 (2015), I.M. J. Biomaterials 33(3), 856866 (2012), A. Kumar et al., Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. 46, 594606 (2018), M. Martnez-Carmona et al., Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Nanotechnology for Cancer Therapy Based on Chemotherapy In fact, most of our current knowledge is based on a few subcutaneous tumor xenograft models that divide vigorously resulting in very high EPR effects. Dalton Trans. Int. J. Colloid Interface Sci. Nature 446(7139), 1023 (2007), A. Verma, F. Stellacci, Effect of surface properties on nanoparticlecell interactions. Biomater. Trace Elem. 24(1), 511518 (2017), X. Dong et al., Mesoporous bamboo charcoal nanoparticles as a new near-infrared responsive drug carrier for imaging-guided chemotherapy/photothermal synergistic therapy of tumor. 115(19), 1093810966 (2015), G. Bozzuto, A. Molinari, Liposomes as nanomedical devices. In a related study, to treat the multidrug resistant cancer cells with elevated Bcl-2 levels, Xu et al. Zhang et al., designed pH sensitive TPGS-PAE nanoparticles, polymeric nanoparticles, wherein doxorubicin and curcumin were co-loaded by self-assembly. 13, 24052426 (2018), B. Xiao et al., Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. As an example, drug-coated nanoparticles completely inhibited lung tumor in mice, leading to enhanced survival rate and reduced adverse effect when compared to the free drug [123]. Lett. Macromol. Rev. Biopharm. A wide range of nanotherapeutics, composed of organic and inorganic nanomaterialshave been developed with multiple types of drugs or molecules for cancer imaging, detection and treatment. 2020 Aug 20;7:193. doi: 10.3389/fmolb.2020.00193. have fabricated and characterized such dual ligandreceptor nanosystems using gold (Au) nanoparticles. 185, 7379 (2018), J.D. Adv. Privacy Recently, a hybrid material based on graphene oxide (GO) coated with -cyclodextrin (CD) and poly(amido amine) dendrimer (DEN) was used to deliver doxorubicin, camptothecin (CPT) and a photosensitizer (protoporphyrin IX (PpIX)). Control. ACS Nano 6(5), 44834493 (2012), F. Lu et al., Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Please enable it to take advantage of the complete set of features! J. Nanomed. Mater. 58, 349364 (2017), Y. Peng et al., Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment. Adv. Tailor-made nanomaterials functionalized with specific ligands can target cancer cells in a predictable manner and deliver encapsulated payloads effectively. Angew. Sahoo, Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Further, HKD appreciates the Centre for Advanced Materials and Industrial Chemistry (CAMIC) in the School of Sciences, RMIT University, Australia for an Honorary Visiting Research Fellowship. Tailor-made nanomaterials functionalized with specific ligands can target cancer cells in a predictable manner and . Many such formulations have been approved [34], opening new avenues toward cancer therapeutics. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. Temozolomide-FaPEC@siRNA exhibited higher cytotoxicity than both temozolomide-FaPEC and temozolomide-PEC, whereas C6 cells incubated with FaPEC@SCR and PEC@SCR exhibited viabilities over 90% even at a very high 100g/mL polymer concentration, indicating low cytotoxicity of carrier, a vital characteristic for in vivo application. Release 200, 138157 (2015), C.K. Ag nanoparticles have been used to deliver drugs that can elevate the therapeutic indices of the drug [148]. Colloids Surf. From the above discussion, it is evident that dendrimers are nanoplatforms which can be tuned for therapeutic applications, and show great promise in the treatment of various cancers. Nano-based modalities provide enhanced transport across biological barriers, enable selective targeting ofmalignanttissues/cells, and offer strategies for sustained release of a drug [21, 22]. Recently, nanographene oxide complexed with upconverting nanoparticles were used for tumor imaging and photothermal therapy, signifying the potential of multifunctional graphene for clinical antitumor treatments [213]. Besides, liposomal co-delivery of chemotherapeutic agents can minimize cancer cell drug resistance and make them more sensitive to individual drugs. The graphene oxide based carrier was found to be effective in inhibiting and killing A549 cells, and displayed lesser toxicity against normal human bronchial epithelial cells [215]. We further elaborate on the topical progress made to date toward nanomaterial engineering for cancer therapy, including current strategies for drug targeting and release for efficient cancer administration. National Library of Medicine Nanoparticles are classified into several main categories. In the paradigm of nanomedicine, nanotechnology is being embraced to obtain effective drug delivery, establish novel in vitro diagnostics, and develop nano-based implants [7, 10, 11]. Nanotechnology has the potential to facilitate the transport of drugs across the blood-brain barrier and to enhance their pharmacokinetic profile. J. Eur. Adv. Sci. In addition, many other factors have a profound consequence on nanomaterials uptake and distribution in cells. Soc. Release 174, 98108 (2014), S. Lakkadwala, J. Singh, Dual functionalized 5-fluorouracil liposomes as highly efficient nanomedicine for glioblastoma treatment as assessed in an in vitro brain tumor model.
Total Archery Challenge 2022 Schedule,
Articles D
